We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. On the regional level, as the Human Development Index ...
The FDA has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneous, chemo-free ...
The Chosun Ilbo on MSN
Chronic lung disease raises lung cancer risk 7-fold in non-smokers
Even non-smokers may face up to seven times higher risk of developing lung cancer if they have a history of chronic lung disease or a family history, according to a new study. A joint research team ...
As smoking rates fall, lung cancer in never-smokers (LCINS) represents an increasing share of lung cancer diagnoses. These cancers are frequently detected at a late stage, when they are less treatable ...
FDA RMAT boosts inhaled gene therapy KB707, delivering IL‑2/IL‑12 to lung tumors; early trial shows responses with manageable ...
Lung cancer has been widely perceived as a disease that predominantly affects men. However, recent epidemiological data indicate that it is increasingly being diagnosed in women. In fact, a large ...
New Members Bring Expertise in Immunology, Genomics, Clinical Oncology, and Patient Advocacy to Guide LCFA's Research Investments and Accelerate Breakthroughs ...
The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after prior targeted treatment.
Late detection, high smoking rates and limited screening have made lung cancer the deadliest cancer in Vietnam, prompting urgent calls to shift toward prevention and early diagnosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results